Scientific Program |
||||||
Stream 3: Gynecologic Oncology
Session 301: Breast Cancer |
|
Time: Afternoon, July 20, 2022 |
|
Chair |
Dr. Qingli Zhu, Professor, Peking Union Medical College Hospital, China |
Co-chair |
Dr. Nira Ben-Jonathan, Professor Emeritus, University of Cincinnati, USA |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Title: Breast Cancer Surgery: Default to Day Case |
14:00-14:25 | Title: Nomogram based on Radiomics Analysis of Primary Breast Cancer Ultrasound Images: Prediction of Axillary Lymph Node Tumor Burden in Patients Dr. Qingli Zhu, Professor, Peking Union Medical College Hospital, China |
14:25-14:50 |
Title: Cancer Immunity and Triple Negative Breast Carcinoma |
14:50-15:15 |
Title: Percutaneous Breast Lesion Ablation. When Avoid Open Surgery? |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Title: Dopamine Receptor Type 1 (D1R) in Breast Cancer: Expression, Signaling, and Therapeutic Targetting |
15:55-16:20 | Title: Breast Radiotherapy: Towards an Individualized Approach Dr. Thomas Mulliez, Professor, Institut Andree Dutreix, University Hospital Brussels, Belgium |
16:20-16:45 |
Title: Prediction of Axillary Lymph Nodes Metastasis based on Preoperative Ultrasound Images |
16:45-17:10 | Title: Diagnostic Accuracy of Contrast-Enhanced Ultrasound Enhancement Patterns for Breast Lesions Dr. Ekaterina A. Busko, Senior Researcher, Petrov’s Research Center of Oncology, Russia |
17:10-17:35 | Speech Opportunity Available |
Session 302: Endometrial Cancer and Ovarian Cancer |
|
Time: Afternoon, July 20, 2022 |
|
Chair |
Dr. Abeer Eddib, Clinical Associate Professor, University at Buffalo Medical School, State University of New York, USA |
Co-chair |
Dr. Emil Anton, Associated Professor, Grigore T. Popa University Iasi Romania, Romania |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Title:5-Hydroxy-4'-Nitro-7-Propionyloxy-Genistein Inhibited Invasion and Metastasis via Inactivating wnt/β-Catenin Signal Pathway in Human Endometrial Carcinoma JEC Cells |
14:00-14:25 |
Title: Endometrial hyperplasia: How, Why and When to Operate? |
14:25-14:50 |
Title: Laparoscopic Sentinel Lymphnode Dissection in Endometrial Cancer. Downsizing Surgical Treatment? |
14:50-15:15 |
Title: Immune Checkpoint Inhibitors and Targeted |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Title: Pure Primary Ovarian Squamous Cell Carcinoma: A Case Report |
15:55-16:20 |
Title: Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP) Gives Chance to Have a Baby Without Donor Eggs |
16:20-16:45 |
Title: The Debate in the Management of Cases with Advanced Ovarian Cancer Dr. Anas Barakat, Clinical Research Fellow In Gynae-Oncology, University Hospitals of Leicester, United Kingdom |
16:45-17:10 | Speech Opportunity Available |
Session 303: HPV and Cervical Cancer |
|
Time: Morning, July 21, 2022 |
|
Chair |
Dr. Sandeep Singhal, Consultant Clinical Oncologist, Northern Centre for Cancer Care, Freeman Hospital, UK |
Co-chair |
Dr. Farr R. Nezhat, Clinical Professor, Weill Cornell Medical College, USA |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: Risk of High-Grade Lesions after HPV-Triage of Atypical Glandular Cell in Cervix Dr. Ingrid Norman, Karolinska University Laboratory, Karolinska University Hospital, Sweden |
09:00-09:25 | Title: Image Guided Adaptive Gynae Brachytherapy in Cervical Cancer: Impact on Clinical Outcome Dr. Sandeep Singhal, Consultant Clinical Oncologist, Northern Centre for Cancer Care, Freeman Hospital, UK |
09:25-09:50 |
Title: An Adsorptive and Antioxidant Vaginal Gel Clears High-Risk HPV- and P16/Ki-67-Associated Abnormal Cytological Cervical Findings: A Subgroup Analysis of a Prospective Randomized Controlled Trial on CIN2 and P16 Positive CIN1 |
09:50-10:15 |
Title: Hormone Receptor Positive Breast Cancer Treatment with Aromatase Inhibitors Associated with Musculoskeletal Pain Causing Non-Adherence? |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: TBD |
10:55-11:20 |
Title: Chromosomal Polymorphisms and Their Role in Recurrent Pregnancy Loss |
11:20-11:45 |
Title: TBD |
11:45-12:10 |
Speech Opportunity Available |
Session 304: Gynecologic Cancer Screening and Prevention |
|
Time: Afternoon, July 21, 2022 |
|
Chair |
Dr. Ting Bao, Director, Memorial Sloan Kettering Cancer Center, USA |
Co-chair |
Dr. Ian N. Hampson, Professor, University of Manchester School of Cancer & Enabling Sciences, UK |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Title: TBD |
14:00-14:25 |
Title: Chemotherapy-Induced Peripheral Neuropathy in Breast and GYN Cancer Survivors |
14:25-14:50 |
Title: Brazilian Experience on the Use of Digital Breast Tomosynthesis, Allied to Conventional Mammography, as a Strategy for Breast Cancer Screening in Brazil: Focusing on Patients with Dense Breasts |
14:50-15:15 |
Title: Age and Cervical Cancer Screening |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Title: TBD Dr. Ian N. Hampson, Professor, University of Manchester School of Cancer & Enabling Sciences, UK |
15:55-16:20 |
Title: TBD Dr. Elizabeth Ordens Castelo Branco, Masters Gynecology-Obstetrics, GynOncology Department-Portugal, Portugal |
16:20-16:45 |
Title: Making Diagnosis of Gestational Trophoblastic Neoplasia:What, When, How to Treat and What to do Next? Dr. Tricia Dewi Anggraeni, Gynecologic Oncologist, National Center Hospital Dr. Cipto Mangunkusumo, University of Indonesia, Indonesia |
16:45-17:10 |
Speech Opportunity Available |
Session 305: Other Gynaecological Oncological |
|
Time: Morning, July 22, 2022 |
|
Chair |
Dr. Kadhim Alabady, Dubai Health Authority, UAE |
Co-chair |
Dr. Hasan Mohammad Alkhudairi, Consultant of Obstetrics & Gynecology, King Faisal Specialist Hospital & Research Centre, Saudi Arabia |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: Ovarian Carcinoma - Molecular Aspects of a Heterogeneous Disease and Future Developments Dr. Steffen Hauptmann, Professor, Department for Pathology, Maastricht University Medical Center, The Netherlands |
09:00-09:25 |
Title: Gynaecological Cancer: What are Strategic Priorities in Dubai? |
09:25-09:50 |
Title: How About Vulvovaginal Diseases-From the Mundane to the Esoteric |
09:50-10:15 | Title: TBD Dr. Michael Morcos, Senior Consultant, Chase Farm Hospital, UK |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: Sexual Life of Cancer and Palliative Women |
10:55-11:20 | Title: Office Myomectomy - Overview Dr. Cinta Vidal Mazo, Department of Obstetrics and Gynecology, University Hospital of Huelva, Spain |
11:20-11:45 |
Title: Pernieal Reconstruction for Vagino-Anorectal Pathology; A Multidisciplinary Approach |
11:45-12:10 |
Speech Opportunity Available |
● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
● REGISTER NOW to secure your attendance
● Program will be released soon
● Call for co-organizers, supporting organizations
● Call for collaborative partners, media and journal
● Call for exhibitors, and posters
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road, High Tech Park, Dalian, LN 116023, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2012-2022 BIT Congress Inc.